D.E. Shaw & Co’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$145K Buy
2021
Q2
Sell
2021
Q1
$282K Sell
2020
Q4
$2.54M Buy
2020
Q3
$1.69M Sell
2020
Q2
$2.48M Buy
2020
Q1
$503K Sell
2019
Q4
$1.02M Buy
2019
Q3
$757K Sell
2019
Q2
$873K Sell
2019
Q1
$1.03M Buy
2018
Q4
$496K Buy
2018
Q3
$123K Buy